Caregen Co.Ltd
Caregen Co., Ltd. engages in the research, development, and commercialization of biomimetic peptides and growth factors worldwide. The company offers cosmeceutical products and food supplements under the Dermaheal, Renokin, Deglusterol, PURILUX, Pelo Baum, Pim-Pim-Paul, Neovert, and PTx brands. It also provides medical devices under the REVOFIL, DR.CYJ, PROSTROLANE, PROSTROLANE B-Series, and CG S… Read more
Caregen Co.Ltd (214370) - Total Liabilities
Latest total liabilities as of June 2025: ₩17.10 Billion KRW
Based on the latest financial reports, Caregen Co.Ltd (214370) has total liabilities worth ₩17.10 Billion KRW as of June 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Caregen Co.Ltd - Total Liabilities Trend (2015–2024)
This chart illustrates how Caregen Co.Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Caregen Co.Ltd Competitors by Total Liabilities
The table below lists competitors of Caregen Co.Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Aces Electronics Co Ltd
TW:3605
|
Taiwan | NT$6.76 Billion |
|
Shandong Fiberglass Group Co Ltd
SHG:605006
|
China | CN¥5.15 Billion |
|
China Man-Made Fiber Corp
TW:1718
|
Taiwan | NT$929.48 Billion |
|
Ser Educacional Sa
SA:SEER3
|
Brazil | R$2.03 Billion |
|
Guangdong Guoli Sci&Tech Co Ltd Class A
SHE:300716
|
China | CN¥910.81 Million |
|
Shandong Hiking International Co Ltd Class A
SHG:600735
|
China | CN¥422.42 Million |
|
Vats Liquor Chain Store Management Joint Stock Co Ltd
SHE:300755
|
China | CN¥2.07 Billion |
|
TA-I Technology Co Ltd
TW:2478
|
Taiwan | NT$2.96 Billion |
Liability Composition Analysis (2015–2024)
This chart breaks down Caregen Co.Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 13.01 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.08 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.07 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Caregen Co.Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Caregen Co.Ltd (2015–2024)
The table below shows the annual total liabilities of Caregen Co.Ltd from 2015 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | ₩17.72 Billion | -11.31% |
| 2023-12-31 | ₩19.98 Billion | +10.43% |
| 2022-12-31 | ₩18.09 Billion | +6.16% |
| 2021-12-31 | ₩17.04 Billion | +49.55% |
| 2020-12-31 | ₩11.40 Billion | -23.20% |
| 2019-12-31 | ₩14.84 Billion | +4.61% |
| 2018-12-31 | ₩14.18 Billion | -6.65% |
| 2017-12-31 | ₩15.19 Billion | +1.14% |
| 2016-12-31 | ₩15.02 Billion | +96.52% |
| 2015-12-31 | ₩7.65 Billion | -- |